Wednesday, May 22, 2013 Last update: 5:04 PM
Company Tech News as it Breaks
Gamida Cell
News articles for Gamida Cell:
Thursday, February 14, 2013
- Gamida Cell’s NiCord® Demonstrates Successful Engraftment in Patients with Hematological Malignancies in Phase I/II StudyGamida Cell announced today the successful results of the Phase I/II study of its second pipeline product NiCord, umbilical cord derived stem cells expanded using the company’s proprietary ... read more
Monday, February 4, 2013
- Gamida Cell’s StemEx® Achieves Primary Endpoint in Phase II/III Clinical StudyGamida Cell announced today that its flagship product, StemEx, reached its primary endpoint of improving overall survival in a Phase II/III study which compared the use of StemEx ... read more